The 2022 Academician and Expert Service Center Science Salon—Academic Symposium on Novel Viral Vaccines Concluded Successfully

Release date:

2022-10-31

Author:

Source:


Abstract

On the morning of October 26, 2022, the “2022 Academic Salon of the Academician and Expert Service Center—Seminar on Novel Viral Vaccines,” hosted by the Beijing Association for Science and Technology and co-organized by the Innovation Service Center of the Beijing Association for Science and Technology and Beijing Minhai Biotechnology Co., Ltd., was held at Minhai Biotechnology. Eight renowned experts in the vaccine field, including Academician Yongxin Yu of the Chinese Academy of Engineering, were invited to attend and deliver remarks. The salon adopted a hybrid format, combining online and offline participation, and was chaired by Liu Jiankai, Executive Deputy General Manager of the company. Zheng Haifa, Director of the Academician and Expert Workstation, provided an overview and summary of the event. Attending academicians and specialists…

On the morning of October 26, 2022, the “2022 Academic Symposium on Novel Viral Vaccines—Science and Technology Salon of the Academician and Expert Service Center,” co-organized by the Beijing Association for Science and Technology and jointly hosted by the Innovation Service Center of the Beijing Association for Science and Technology and Beijing Minhai Biotechnology Co., Ltd., was held at Minhai Biotechnology. Eight renowned experts in the vaccine field, including Academician Yu Yongxin of the Chinese Academy of Engineering, were invited to attend the symposium and deliver remarks.

The symposium was held in a hybrid online–offline format, chaired by Liu Jiankai, Executive Deputy General Manager of the company. Zheng Haifa, Director of the Academician and Expert Workstation, provided an overview and summary of the event. Attending academicians and experts exchanged views and discussed the research progress of three projects: the inactivated COVID‑19 vaccine (Vero cell), the quadrivalent enterovirus (EV‑A71, CV‑A6, CV‑A10, CV‑A16) inactivated vaccine (Vero cell), and the lyophilized live attenuated varicella vaccine. They highly commended the achievements made in these projects and offered valuable insights on aspects such as project planning and technical challenges, thereby contributing positively to the smooth advancement of subsequent work.

“The 2022 Academician and Expert Service Center Science Salon—Symposium on Novel Virus Vaccines” was the first large-scale salon event hosted by Minhai Biotechnology. The event provided valuable intellectual and technical support for the company’s technological innovation, R&D enhancement, and the commercialization of research outcomes, laying a solid foundation for the further development of vaccines that are new to China and globally.

Recommended Reading


Batch Release Status of the Company’s Products in 2026


The company's product 2026 annual batch issuance situation is as follows:

2026-07-23

Good News | Another Star Award! Minhai Biotechnology has once again been recognized as a “Five-Star Green Credit Enterprise” in Daxing District.


Recently, the Daxing District Bureau of Ecology and Environment completed the fifth round of corporate green credit rating for 2025 and officially released the “2025 Daxing District Green Credit Enterprise Directory.” Thanks to its robust environmental management system, consistent compliance performance, and outstanding achievements in energy conservation and carbon reduction, Minhai Biotechnology has once again been awarded the region’s highest “Five-Star Green Credit Enterprise” rating. The Daxing District’s corporate green credit assessment covers five major categories—environmental compliance, pollution control and emission reduction, low‑carbon circular economy, scientific management, and social contribution—comprising a total of 30 sub‑indicators. With stringent standards and comprehensive evaluation, the program employs dynamic review and a veto‑based mechanism, with the Five‑Star rating representing the highest level of ecological credit in the district.

2026-07-15

Good News | The Party Branch of Minhai Biotechnology has been awarded the “Two Excellences and One Pioneer” honor in Beijing’s emerging sectors, as well as a park‑level commendation.


Recently, Beijing held a grand commendation conference for the “Two Excellences and One Pioneer” initiative in emerging sectors. The “Two New” Working Committee of the CPC Beijing Municipal Committee recognized outstanding Communist Party members, exemplary Party affairs workers, and advanced primary-level Party organizations across the city’s emerging fields. The Party branch of Beijing Minhai Biotechnology Co., Ltd. was honored as an advanced primary-level Party organization in Beijing’s emerging sectors. Wu Chengyu, the branch secretary, attended the ceremony in person to receive the award. At the event, the Party flag flew proudly amid a solemn atmosphere, and the awardees, adorned with honor ribbons and holding certificates and medals, jointly witnessed this prestigious municipal recognition. This designation as an advanced primary-level Party organization at the municipal level represents the “Two New” Working Committee of the Municipal Party Committee’s high appraisal of the Minhai Biotechnology Party branch.

2026-07-09